Skip to content

Helium Neon Laser Versus Gallium Arsenide Laser

Helium Neon Laser Versus Gallium Arsenide Laser In Healing Of Venous Ulcers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04689620
Enrollment
60
Registered
2020-12-30
Start date
2020-12-26
Completion date
2021-02-28
Last updated
2020-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Leg Ulcer

Brief summary

There will be different effects for different laser wavelengths in treatment of venous ulcer.

Detailed description

The cost of treating venous ulcer can vary within wide limits and depends on the technology used. In the countries of the European community, the closure of one ulcer as an outpatient procedure costs 800-1500 euros, and supporting anti-relapse treatment makes 100-150 euros per month. In the United States, for closure of venous ulcer within 3 months, direct medical costs reach US$1500- 2000. Prolongation of the treatment for a longer time results in increased cost up to US$30 000 or more. Poor efficiency of the known methods of treating patients with venous ulcer necessitates the search for new ways and modes of laser therapy (LT) based on a comprehensive approach. Application of physical therapy, primarily with the use of LLLT, capable of influencing various stages in the pathogenesis of the disease, allows a high therapeutic effect in many cases, while ensuring systemic response of the patient's body with the proper exposure procedure. So, the current study will be conducted to compare the effect of different laser wavelengths on venous ulcers and provide an effective treatment method for patients with venous ulcers with low cost and in short duration.

Interventions

DEVICElaser

treating the venous ulcer with laser

Sponsors

Mahmoud Awad Ramadan Elkholy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* All patients approximately the same age (50-60). * All patients had venous leg ulcers just above medial malleolus. The common cause of ulcers for all cases was venous insufficiency. * All patients with conscious.

Exclusion criteria

* All patients had no diabetes or blood problems. * any immunity disorder affect wound heaing.

Design outcomes

Primary

MeasureTime frameDescription
wound surface areatwo monthsmeasuring the ulcer surface area by smart phone application
number of bacteria in woundtwo monthsmeasuring number of bacteria by colony count

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026